MacroGenics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MacroGenics generated cash of -$78,205,000, which is more than the previous year. Cash used in financing activities reached the amount of $150,361,000 last year. Net change in cash is therefore -$7,928,000.
Cash Flow
| 2014 | -32.75M | -3.57M | 77.44M |
|---|---|---|---|
| 2015 | -13.66M | -152.10M | 204.34M |
| 2016 | -43.67M | -70.24M | 1.85M |
| 2017 | 14.40M | 77.87M | 35.34M |
| 2018 | -153.23M | 56.64M | 104.99M |
| 2019 | -134.27M | -79.35M | 119.97M |
| 2020 | -111.89M | -7.78M | 174.34M |
| 2021 | -143.83M | -36.60M | 122.77M |
| 2022 | -86.95M | 70.71M | 1.65M |
| 2023 | -78.20M | -80.08M | 150.36M |
MGNX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 108.88M | 123.46M | 181.13M | 126.47M | 220.12M | 211.72M | 84.09M | 196.17M | 157.59M | 116.48M |
Operating activities | ||||||||||
Net income | -9.05M | -119.75M | -202.11M | -129.73M | -151.81M | -171.45M | -19.62M | -58.52M | -20.14M | -38.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.64M | 11.86M | 11.25M | 11.95M | 10.84M | 8.27M | 7.22M | 7.60M | 2.86M | 1.82M |
Stock-based compensation expense | 18.37M | 20.43M | 23.12M | 20.67M | 19.57M | 16.52M | 14.74M | 12.16M | 7.84M | 3.24M |
| Deferred income tax benefit | 18.37M | 20.43M | 23.12M | 20.67M | 19.57M | 16.52M | 14.74M | 12.16M | 7.84M | 3.24M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 45.85M | -45.83M | 12.69M | -10.33M | 16.83M | -15.94M | -10.87M | -1.54M | 1.71M | -931K |
Inventories | 230K | 55K | -6.42M | 554K | -9.63M | -4.62M | 11.83M | -291K | 1.49M | -269K |
Accounts payable | 1.28M | -10.86M | 7.12M | 3.72M | 787K | 1.55M | -1.54M | 2.23M | -163K | -1.5M |
Cash generated by operating activities | -78.20M | -86.95M | -143.83M | -111.89M | -134.27M | -153.23M | 14.40M | -43.67M | -13.66M | -32.75M |
Investing activities | ||||||||||
Purchases Of Investments | -239.68M | -120.60M | -231.20M | -223.74M | -264.39M | -132.75M | -135.12M | -347.76M | -142.91M | 0 |
Investments In Property Plant And Equipment | -1.76M | -3.62M | -6.20M | -5.90M | -4.28M | -24.95M | -29.40M | -11.38M | -9.19M | -3.57M |
Acquisitions Net | 0 | -74.33M | 30.40M | 1.87M | 75.06M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -80.08M | 70.71M | -36.60M | -7.78M | -79.35M | 56.64M | 77.87M | -70.24M | -152.10M | -3.57M |
Financing activities | ||||||||||
Common Stock Issued | 616K | 1.08M | 117.81M | 170.45M | 118.65M | 103.25M | 34.24M | 1.89M | 203.46M | 76.71M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -2.01M | 0 | -260K | -40K | -39K | -29K | -19K |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 150.36M | 1.65M | 122.77M | 174.34M | 119.97M | 104.99M | 35.34M | 1.85M | 204.34M | 77.44M |
Net Change In Cash | -7.92M | -14.58M | -57.66M | 54.65M | -93.65M | 8.40M | 127.62M | -112.07M | 38.58M | 41.11M |
Cash at end of period | 100.95M | 108.88M | 123.46M | 181.13M | 126.47M | 220.12M | 211.72M | 84.09M | 196.17M | 157.59M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |